Industry focus
In addition to his role as chairman of Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York-based Brad Karp remains a sought-after trial lawyer, notably representing Regeneron Pharmaceuticals in a False Claims Act and Anti-Kickback Statute suit brought by the DOJ, alleging it paid kickbacks to a co-pay foundation with the intention of increasing sales of its macular degeneration drug Eylea and thereby increase reimbursement rates from Medicare.
Legal 500 Editorial commentary
- Profile
Mentions
Dispute resolution
Corporate investigations and white-collar criminal defense
Leading lawyers: Advice to corporatesDispute resolution
Financial services litigation
Dispute resolution
General commercial disputes
Dispute resolution
Appellate: courts of appeals / Appellate: supreme courts (states and federal)
Dispute resolution
Securities litigation: defense
Intellectual property